BWXTIndustrials · Aerospace & DefenseThe 16 Wall Street analysts covering BWX Technologies, Inc. hold a median 12-month price target of $233 — +33.8% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 64 of 100 as at 1 Aug 2026 — in the upper half.
Consensus tells you what everyone already believes. The model scores BWX Technologies, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Revisions (84): Analysts have, on balance, been raising their forecasts.
Accruals (29): A large share of reported profit has not shown up as cash, or the balance sheet is expanding quickly — both tend to unwind.
Size (12): Larger than most of the companies we track — more scrutinised, less often mispriced.
The rank is the raw material. Whether the rules would actually own BWX Technologies, Inc. — and when they’d sell — is the membership.
The bullish and bearish analyst opinions on BWXT, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
The green dot is the last close — the median target sits +33.8% from it.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 27 July 2026 | JP Morgan | Initiates | Overweight | $230 |
| 18 June 2026 | Seaport Global | Upgrade | Buy | $245 |
| 18 June 2026 | Seaport Global | Upgrade | Buy | — |
| 15 May 2026 | Deutsche Bank | Upgrade | Buy | — |
| 11 May 2026 | Truist Securities | Maintains | Hold | — |
| 1 Apr 2026 | Wells Fargo | Initiates | Underweight | — |
| 25 Mar 2026 | B of A Securities | Maintains | Buy | — |
| 12 Mar 2026 | TD Securities | Initiates | Buy | — |
| 26 Feb 2026 | BTIG | Maintains | Buy | — |
| 20 Jan 2026 | Seaport Global | Downgrade | Neutral | — |
| 13 Nov 2025 | B of A Securities | Maintains | Buy | — |
| 7 Nov 2025 | BTIG | Maintains | Buy | — |
| 4 Nov 2025 | Truist Securities | Maintains | Hold | — |
| 15 Oct 2025 | Truist Securities | Maintains | Hold | — |
| 8 Oct 2025 | Deutsche Bank | Maintains | Hold | — |
| 10 Sept 2025 | Northland Capital Markets | Initiates | Outperform | — |
| 13 Aug 2025 | B of A Securities | Maintains | Buy | — |
| 6 Aug 2025 | Deutsche Bank | Maintains | Hold | — |
| 6 Aug 2025 | Maxim Group | Downgrade | Hold | — |
| 5 Aug 2025 | Truist Securities | Maintains | Hold | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 17% of US stocks
Cheaper than 27% of US stocks
Cheaper than 8% of US stocks
Cheaper than 7% of US stocks
Higher than 77% of US stocks
Higher than 62% of US stocks
Higher than 26% of US stocks
Higher than 67% of US stocks
Higher than 70% of US stocks
Higher than 87% of US stocks
Higher than 81% of US stocks
Higher than 13% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The nearest names by industry and size, scored by the same model — like for like.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. BWXT appears on the weeks it earns a place.
BWX Technologies reported second-quarter 2026 revenue growth of 18% and raised its full-year financial outlook, citing continued demand across nuclear national security and commercial power markets.
Why it matters — A BWXT watcher would care because the revenue growth and raised full-year outlook point to strengthening business in the company's two key markets.
BWX Technologies reported second-quarter earnings of $1.07 per share, topping the Zacks Consensus Estimate of $1.01 per share and above the $1.02 per share it earned a year earlier. The company also beat revenue estimates for the quarter.
Why it matters — The earnings and revenue beats signal stronger-than-expected quarterly results compared with analyst expectations.
BWX Technologies reported second quarter 2026 results, with management noting results came in ahead of expectations. The company cited strong execution across its business, high growth in Commercial Operations, and good free cash flow generation.
Why it matters — The second-quarter results came in ahead of expectations with strong commercial growth and free cash flow, which BWXT watchers would see as a positive indicator for the company's performance.
BWX Technologies has entered into a definitive agreement to sell its medical business, which includes BWXT Medical and Kinectrics' stable medical isotopes business, to healthcare investor Nordic Capital in a transaction valued at up to $800 million.
Why it matters — The divestiture allows BWXT to concentrate its resources and capital on its core business operations.
BWX Technologies is set to report its second-quarter results, with demand in nuclear, medical and defense supporting sales, though earnings are expected to edge slightly lower.
Why it matters — A BWXT watcher would care because the Q2 report will show whether end-market demand translated into results that beat or fell short of the lowered earnings expectations.
The 16 Wall Street analysts covering BWX Technologies, Inc. have a median 12-month price target of $233, with estimates ranging from $200 to $290. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 16 analysts covering BWX Technologies, Inc., 12 rate it a Buy, 3 a Hold and 1 a Sell. Ticker Nerd's systematic factor model ranks BWX Technologies, Inc. 64 out of 100 across roughly 4,600 US stocks as at 1 Aug 2026. None of this is personal advice — it does not consider your circumstances.
As at 1 Aug 2026, BWX Technologies, Inc. ranks 64 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Revisions (84 of 100).
No one can know that. What the data says: the median 12-month target from 16 analysts implies +33.8% from the last close, and Ticker Nerd's factor model ranks BWX Technologies, Inc. 64 out of 100 as at 1 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering BWX Technologies, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for BWXT are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $200 to $290 over the next 12 months.
BWX Technologies, Inc. returned +16.9% over the 12 months to 3 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.
BWX Technologies Inc. is a nuclear technology company headquartered in Lynchburg, Virginia, specializing in the design, manufacture, and servicing of nuclear components and fuel for government and commercial customers.
The most recent item we track (MarketBeat, 3 Aug 2026): "BWX Technologies Q2 Earnings Call Highlights". BWX Technologies reported second-quarter 2026 revenue growth of 18% and raised its full-year financial outlook, citing continued demand across nuclear national security and commercial power markets.
BWX Technologies Inc. is a nuclear technology company headquartered in Lynchburg, Virginia, specializing in the design, manufacture, and servicing of nuclear components and fuel for government and commercial customers. The company operates through Government Operations and Commercial Operations segments, supporting critical nuclear programs in defense, energy, and medical applications. BWX Technologies produces precision naval nuclear reactors and fuel for maritime defense, as well as specialized nuclear components, fuels, and assemblies for various government uses. In the commercial market, it supplies nuclear steam generators, reactor components, fuel handling systems, and containers for the storage of nuclear fuel and high-level nuclear waste, alongside lifecycle support and management services for nuclear power plants. The company also participates in the medical field by manufacturing medical radioisotopes, radiopharmaceuticals, and related devices, contributing to diagnostic and therapeutic applications. Through these activities, BWX Technologies plays a significant role in highly regulated, mission-critical nuclear sectors across the United States, Canada, and international markets.
CEO Mr. Rex D. Geveden · 8,700 employees · United States · https://www.bwxt.com